Microbot Medical Inc. Enters into Inducement Agreement for Preferred Investment Options

On September 14, 2025, Microbot Medical Inc. entered into an inducement agreement with certain holders of existing preferred investment options (PIOs) to purchase shares of the company's common stock. The agreement involves the issuance of new series J preferred investment options (New PIOs) to purchase up to 13,989,115 shares of common stock at an exercise price of $4.50 per share. The New PIOs will be exercisable six months after issuance and will expire two years thereafter. The company received gross proceeds of approximately $25.2 million from the exercise of certain existing PIOs in the first closing and expects to receive an additional $4.0 million in the second closing. The net proceeds will be used for the development, commercialization, and regulatory activities of the company's LIBERTY® Robotic System, potential acquisitions, and general corporate purposes. The company also agreed to certain restrictions on the issuance and sale of its common stock for 90 days following the first closing and not to enter into a variable rate transaction for six months.